Here is a link to the EASD website that shows the poster and a Dr. Wong narrated poster presentation of the "Apabetalone (RVX-208) acts on epigenetics to lower Major Adverse Cardiovascular Events (MACE) in diabetes mellitus patients with atherosclerosis via microbiome activity" abstract that was presented at EASD in Munich last week. Thanks to F6 on the Investor Village board for first posting.